Jonathan Allan - Net Worth and Insider Trading
Jonathan Allan Net Worth
The estimated net worth of Jonathan Allan is at least $36,710 dollars as of 2024-05-16. Jonathan Allan is the GENERAL COUNSEL & CORP SEC of Stoke Therapeutics Inc and owns about 2,598 shares of Stoke Therapeutics Inc (STOK) stock worth over $36,710. Details can be seen in Jonathan Allan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jonathan Allan has not made any transactions after 2024-03-28 and currently still holds the listed stock(s).
Transaction Summary of Jonathan Allan
Jonathan Allan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan Allan owns 1 companies in total, including Stoke Therapeutics Inc (STOK) .
Click here to see the complete history of Jonathan Allan’s form 4 insider trades.
Insider Ownership Summary of Jonathan Allan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STOK | Stoke Therapeutics Inc | 2024-03-28 | General Counsel & Corp Sec |
Jonathan Allan Latest Holdings Summary
Jonathan Allan currently owns a total of 1 stock. Jonathan Allan owns 2,598 shares of Stoke Therapeutics Inc (STOK) as of March 28, 2024, with a value of $36,710.
Latest Holdings of Jonathan Allan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STOK | Stoke Therapeutics Inc | 2024-03-28 | 2,598 | 14.13 | 36,710 |
Holding Weightings of Jonathan Allan
Jonathan Allan Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan Allan has made a total of 3 transactions in Stoke Therapeutics Inc (STOK) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Stoke Therapeutics Inc is the sale of 5,126 shares on March 28, 2024, which brought Jonathan Allan around $67,663.
Insider Trading History of Jonathan Allan
- 1
Jonathan Allan Trading Performance
Jonathan Allan Ownership Network
Jonathan Allan Owned Company Details
What does Stoke Therapeutics Inc do?
Who are the key executives at Stoke Therapeutics Inc?
Jonathan Allan is the General Counsel & Corp Sec of Stoke Therapeutics Inc. Other key executives at Stoke Therapeutics Inc include Chief Medical Officer Barry Ticho , 10 percent owner Skorpios Trust , and director & CEO Kaye Edward M. Md .
Stoke Therapeutics Inc (STOK) Insider Trades Summary
Over the past 18 months, Jonathan Allan made 3 insider transaction in Stoke Therapeutics Inc (STOK) with a net sale of 9,423. Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 149,116 shares made by Barry Ticho , a net sale of 3,600,000 shares made by Skorpios Trust , and a net sale of 11,150 shares made by Kaye Edward M. Md .
In summary, during the past 3 months, insiders sold 3,650,973 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 3,650,973 shares. During the past 18 months, 3,777,921 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,777,921 shares.
Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Stoke Therapeutics Inc Insider Transactions
Jonathan Allan Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan Allan. You might contact Jonathan Allan via mailing address: C/o Stoke Therapeutics, Inc., 45 Wiggins Avenue, Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
